Liver transplantation for hepatic and biliary malignancy

Seminars in Liver Disease

Volumn 20, Issue 4, 2000, Pages 425-436

  Wall, W J ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Liver; Malignancy; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; MITOXANTRONE;

ADJUVANT CHEMOTHERAPY; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CANCER; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; HEPATOBLASTOMA; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; NEUROENDOCRINE TUMOR; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR VOLUME;

BILIARY TRACT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM RECURRENCE, LOCAL; NEUROENDOCRINE TUMORS; PALLIATIVE CARE; PATIENT SELECTION; PROGNOSIS; TREATMENT OUTCOME;

EID: 0034523202     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13154     Document Type: Article

References (95)

1. Clinical and pathological observations after orthotopic transplantation of the human liver
2. Orthotopic liver transplantation: The first 60 patients
3. Experiences with liver transplantation in Hanover
4. Is there a place for liver grafting for malignancy?
5. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
6. Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastases classification does not have prognostic power
7. Hepatic transplantation for primary and metastatic cancers of the liver
8. Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy
9. Liver transplantation for malignant disease. Results in 93 consecutive patients
10. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence
11. Hepatic transplantation in Europe. First report of the European Liver Transplant Registry
12. Role of liver transplantation in cancer therapy
13. Experience in 1000 liver transplants under cyclosporine-steroid therapy: A survival report
14. Prospective study of afetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma
15. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population
16. Small hepatic nodules in cirrhosis: Ultrasonographic, CT, and MR imaging findings
17. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients
18. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation
19. Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT
20. Magnetic resonance imaging of small hepatocellular carcinoma
21. The diagnosis of small hepatocellular carcinomas: Efficacy of various imaging procedures in 100 patients
22. Hepatocellular carcinoma in patients who undergo liver transplantation: Sensitivity of CT with iodized oil
23. Transcatheter arterial chemotherapy using doxorubicin, iodized oil and gelfoam embolization in hepatocellular carcinoma
24. Randomized trial of targeted chemotherapy with lipoidal and 5-epidoxorubicin compared with symptomatic treatment for hepatoma
25. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
26. Groupe d'etude et de traitment du carcinome hepatocellulaire: A comparison of lipoidal chemoembolization and conservative treatment for unresectible hepatocellular carcinoma
27. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?
28. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series
29. International Union Against Cancer (UICC) TNM classification of malignant tumors
30. Natural history of hepatocellular carcinoma and progress in relation to treatment
31. Hepatic resection versus transplantation for hepatocellular carcinoma
32. Role of liver transplantation in the treatment of unresectible liver cancer
33. Liver transplantation for hepatocellular carcinoma: A registry report of the impact of tumor characteristics on outcome
34. Liver Transplantation for primary hepatocellular carcinoma: Tumor size and number determine outcome
35. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study
36. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study
37. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: A pilot study in 20 patients
38. Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma
39. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma
40. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma
41. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma
42. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection?
43. Liver transplantation for hepatocellular carcinoma: Results with preoperative chemoembolization
44. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver
45. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
46. Influence of preoperative transarterial lipoidal chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis
47. Accelerated growth of recurrent hepatocellular carcinoma after liver transplantation
48. Effect of systemic cyclosporine on recurrence after liver transplantation in a model of hepatocellular cancer
49. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
50. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
51. Experience of orthotopic liver transplantation and hepatic resection for hepatoceltular carcinoma of less than 8 cm in patients with cirrhosis
52. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis
53. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma
54. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis
55. De Novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis
56. Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: A systemic review
57. Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathological features
58. Characteristics of fibrolamellar hepatocellular carcinoma
59. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver
60. Results of hepatic resection and transplantation for fibrolamellar carcinoma
61. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation
62. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion Adriamycin chemotherapy: A report from the Children's Cancer Study Group
63. Treatment of hepatoblastoma: Less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin
64. Resection, including transplantation for hepatoblastoma and hepatocellular carcinoma: Impact on survival
65. Liver transplantation for hepatoblastoma. The American experience
66. Treatment of epitheloid hemangioendothelioma with liver transplantation
67. Hepatic resection and transplantation for peripheral cholangiocarcinoma
68. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation
69. Liver resection for Hilar and peripheral cholangiocarcinomas: A study of 62 cases
70. Is liver transplantation indicated for cholangiocarcinoma?
71. Radiotherapy and multimodality management of cholangiocarcinoma
72. Extended resection for hilar cholangiocarcinoma
73. Surgical treatment in proximal bile duct cancer. A single center experience
74. Advances in primary sclerosing cholangitis
75. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis
76. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study
77. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis
78. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
79. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangirls undergoing liver transplantation
80. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis
81. CA19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis
82. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience
83. Gastrointestinal neuroendocrine tumors
84. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production and survival
85. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas
86. Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver
87. Liver transplantation for metastatic neuroendocrine carcinoma. An analysis of 103 patients
88. Metastatic endocrine tumors: Is there a place for liver transplantation
89. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors
90. Liver transplantation for metastatic neuroendocrine tumors
91. Results of liver transplantation for gastropancreatic tumor metastases
92. Liver transplantation for primary and secondary hepatic apudomas
93. Should abdominal cluster transplantation be abandoned?